General Archive

-
News releasesLifeArc Ventures: Ozlo Sleep Emerges from Stealth and Unveils Flagship Product Ozlo Sleepbuds®
Ozlo Sleep (Ozlo), a science-driven sleep and audio technology company, emerged from stealth today with plans to launch Ozlo Sleepbuds®, a…
-
News releasesLifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa
Joint initiative part of LifeArc’s £100 million Translational Challenge to help address rare disease translational science.
-
News releasesGroundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
-
News releasesNew UK-based research project brings together world-leading institutions to transform care for people living with dementia
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
-
News releasesLifeArc strengthens Board of Trustees with new appointments
Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem join LifeArc’s Board of Trustees as Non-Executive Directors.
-
News releasesNew programme to move potential MND drugs into clinical trials faster
EXPERTS-ALS to screen candidate drugs at scale and identify those that should be fast-tracked to larger clinical trials
-
News releasesLifeArc and Sarcoma UK fund research to guide treatment decisions in rare cancer
£150,000 grant will fund a study of a biomarker test that could improve outcomes for patients with a rare sarcoma…
-
News releasesLifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.
-
News releasesLifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections
Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)
-
News releasesDr Jason Slingsby joins LifeArc as Chief Business Officer
Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.
-
News releasesLifeArc launches £40m funding call to create Translational Rare Disease Centres
Centres to become focal points for rare disease research translation and engagement with the patient community across the UK.
-
News releasesLifeArc plans two major funding calls to boost translational research in rare disease & lung health in cystic fibrosis
The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.
